Science Explorer Back to mapMap
Discussion
Company · Södertälje · Sweden

Nanologica (Sweden)

Research works
10
▲ 95% vs 2018-21
Citations
431
44.7 per fractional work
Top-10% rate
18.8%
all institutions 10.0%
Open access
82%
world 40%
International
46%
world 18%

Not ranked overall: Nanologica (Sweden) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Nanologica (Sweden) work in?

In all years, 53% of research at Nanologica (Sweden) is in Physical Sciences, 28% in Life Sciences. Its largest fields are Materials Science (39%), Medicine (16%), Pharmacology, Toxicology and Pharmaceutics (10%). It does 1.3× the world's share of Life Sciences.

Physical Sciences: 5 fractional works · 53.3% of its workMaterials Science: 4 fractional works · 39.2% of its workMaterials Chemistry: 2 fractional works · 22.3% of its workBiomaterials: 1 fractional works · 10.7% of its workCeramics and Composites: 0 fractional works · 3.4% of its workMetals and Alloys: 0 fractional works · 1.1% of its workPolymers and Plastics: 0 fractional works · 1.1% of its workSurfaces, Coatings and Films: 0 fractional works · 0.5% of its workChemistry: 1 fractional works · 6.0% of its workInorganic Chemistry: 0 fractional works · 3.2% of its workSpectroscopy: 0 fractional works · 2.0% of its workPhysical and Theoretical Chemistry: 0 fractional works · 0.8% of its workEngineering: 0 fractional works · 5.2% of its workBiomedical Engineering: 0 fractional works · 2.3% of its workElectrical and Electronic Engineering: 0 fractional works · 1.8% of its workCivil and Structural Engineering: 0 fractional works · 1.1% of its workEnvironmental Science: 0 fractional works · 1.6% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 1.1% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.4% of its workEnergy: 0 fractional works · 1.3% of its workRenewable Energy, Sustainability and the Environment: 0 fractional works · 1.3% of its workLife Sciences: 3 fractional works · 28.3% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 10.4% of its workPharmaceutical Science: 1 fractional works · 10.4% of its workNeuroscience: 1 fractional works · 7.1% of its workCellular and Molecular Neuroscience: 0 fractional works · 3.2% of its workDevelopmental Neuroscience: 0 fractional works · 1.8% of its workNeurology: 0 fractional works · 1.2% of its workSensory Systems: 0 fractional works · 0.8% of its workBiochemistry, Genetics and Molecular Biology: 0 fractional works · 5.1% of its workMolecular Biology: 0 fractional works · 4.3% of its workCancer Research: 0 fractional works · 0.4% of its workMolecular Medicine: 0 fractional works · 0.4% of its workImmunology and Microbiology: 0 fractional works · 5.0% of its workImmunology: 0 fractional works · 4.0% of its workVirology: 0 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 0 fractional works · 0.8% of its workFood Science: 0 fractional works · 0.8% of its workHealth Sciences: 2 fractional works · 17.2% of its workMedicine: 2 fractional works · 16.4% of its workPulmonary and Respiratory Medicine: 0 fractional works · 4.0% of its workSurgery: 0 fractional works · 2.3% of its workPharmacology: 0 fractional works · 1.3% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.3% of its workOncology: 0 fractional works · 1.1% of its workEpidemiology: 0 fractional works · 0.8% of its workInfectious Diseases: 0 fractional works · 0.8% of its workOtorhinolaryngology: 0 fractional works · 0.8% of its workPhysiology: 0 fractional works · 0.8% of its workDermatology: 0 fractional works · 0.6% of its workGenetics: 0 fractional works · 0.6% of its workNeurology: 0 fractional works · 0.6% of its workUrology: 0 fractional works · 0.6% of its workRheumatology: 0 fractional works · 0.4% of its workHealth Professions: 0 fractional works · 0.8% of its workComplementary and Manual Therapy: 0 fractional works · 0.8% of its workSocial Sciences: 0 fractional works · 1.1% of its workPsychology: 0 fractional works · 1.1% of its workExperimental and Cognitive Psychology: 0 fractional works · 1.1% of its workALL ITS WORKNanologica(Sweden)10fractional works, all years
Life Sciences28%Physical Sciences53%Health Sciences17%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 13 fields, with their numbers
    1. Materials Science439.2%
    2. Chemistry16.0%
    3. Engineering05.2%
    4. Environmental Science01.6%
    5. Energy01.3%
    1. Pharmacology, Toxicology and Pharmaceutics110.4%
    2. Neuroscience17.1%
    3. Biochemistry, Genetics and Molecular Biology05.1%
    4. Immunology and Microbiology05.0%
    5. Agricultural and Biological Sciences00.8%
    1. Medicine216.4%
    2. Health Professions00.8%
    1. Psychology01.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.21× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.08× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 5.09× its world share, 0 worksImmunology and Micro…Neuroscience: 5.13× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 49.11× its world share, 0 worksPharmacology, Toxico…Engineering: 0.38× its world share, 0 worksEngineeringMaterials Science: 3.31× its world share, 0 worksMaterials ScienceMedicine: 2.10× its world share, 1 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 49.1×. Every wedge is a field page.

All 8 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics49.11×0 works
  2. Neuroscience5.13×0 works
  3. Immunology and Microbiology5.09×0 works
  4. Materials Science3.31×0 works
  5. Medicine2.10×1 works
  6. Agricultural and Biological Sciences1.21×0 works
  7. Biochemistry, Genetics and Molecular Biology1.08×0 works
  8. Engineering0.38×0 works

What are the most cited papers from Nanologica (Sweden)?

The most cited paper from Nanologica (Sweden) is "MWCNTs of different physicochemical properties cause similar inflammatory responses, but differences in transcriptional and histological markers of fibrosis in mouse lungs" (Sarah Søs Poulsen, Anne Thoustrup Saber, Andrew Williams et al., 2015), with 186 citations. Next come "High-resolution imaging with SEM/T-SEM, EDX and SAM as a combined methodical approach for morphological and elemental analyses of single engineered nanoparticles" (147) and "Micro CT visualization of silver nanoparticles in the middle and inner ear of rat and transportation pathway after transtympanic injection" (72).

Most cited papers
#PaperReleasedCitations
1 MWCNTs of different physicochemical properties cause similar inflammatory responses, but differences in transcriptional and histological markers of fibrosis in mouse lungs Sarah Søs Poulsen, Anne Thoustrup Saber, Andrew Williams et al. · Toxicology and Applied Pharmacology Open access 3 Jan 2015 186
2 High-resolution imaging with SEM/T-SEM, EDX and SAM as a combined methodical approach for morphological and elemental analyses of single engineered nanoparticles Steffi Rades, Vasile‐Dan Hodoroaba, T. Salge et al. · RSC Advances Open access 7 Oct 2014 147
3 Micro CT visualization of silver nanoparticles in the middle and inner ear of rat and transportation pathway after transtympanic injection Jing Zou, Markus Hannula, Superb K. Misra et al. · Journal of Nanobiotechnology Open access 2015 72
4 Macrophage activation status determines the internalization of mesoporous silica particles of different sizes: Exploring the role of different pattern recognition receptors Audrey Gallud, Olesja M. Bondarenko, Neus Feliu et al. · Biomaterials 27 Dec 2016 71
5 Transcriptional profiling identifies physicochemical properties of nanomaterials that are determinants of the in vivo pulmonary response Sabina S. Halappanavar, Anne Thoustrup Saber, Nathalie Decan et al. · Environmental and Molecular Mutagenesis 11 Dec 2014 68
All 36 most cited papers, with filters and sorting

Which research topics does Nanologica (Sweden) publish most on?

By volume in 2022-now: Advanced Drug Delivery Systems, Inhalation and Respiratory Drug Delivery, Colorectal and Anal Carcinomas and Drug Solubulity and Delivery Systems.

  1. 1 Advanced Drug Delivery Systems Pharmaceutical Science 0 works
  2. 2 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 0 works
  3. 3 Colorectal and Anal Carcinomas Surgery 0 works
  4. 4 Drug Solubulity and Delivery Systems Pharmaceutical Science 0 works
  5. 5 Esophageal Cancer Research and Treatment Surgery 0 works
  6. 6 Microencapsulation and Drying Processes Food Science 0 works
  7. 7 Aerosol Filtration and Electrostatic Precipitation Electrical and Electronic Engineering 0 works
  8. 8 Mesoporous Materials and Catalysis Materials Chemistry 0 works
  9. 9 Glycosylation and Glycoproteins Research Molecular Biology 0 works
  10. 10 Nanoparticle-Based Drug Delivery Biomaterials 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available82.0%not open18.0%

World: 40% of research is openly available.

with international co-authors46.0%domestic only54.0%

World: 18% is written across borders.

How has Nanologica (Sweden)'s research output changed?

Output in 2022-2025 was 95% higher than in 2018-2021.

still counting2010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Nanologica (Sweden) as a percentage of every work published that year, 0.000014% in 2024.

still counting0.000020%0.000040%0.000060%Nanologica (Sweden)0.0000056% in 202520102020

Fractional works of Nanologica (Sweden) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Södertälje

All research institutions in Södertälje

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Nanologica (Sweden). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.